Heron Therapeutics, Inc. (NASDAQ:HRTX)

CAPS Rating: No stars

A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.

Recs

1
Player Avatar EvanBuck (99.80) Submitted: 12/31/2012 1:29:23 PM : Underperform Start Price: $10.82 HRTX Score: +28.63

This stock was listed on the "pumps and dumps" watch list.

Featured Broker Partners


Advertisement